Fees and payments

We are required to recover our costs for all activities that fall within the scope of the Therapeutic Goods Act 1989, including our public health responsibilities.

• A fee is charged for a service, such as a product evaluation.
• A charge is a form of tax on regulated industry and is applied annually based on a 1 July to 30 June financial year.

Each year we consult with industry representative bodies in relation to proposed changes to fees and charges and publish a Cost Recovery Implementation Statement (CRIS). The CRIS provides information on how we implement cost recovery activities associated with the registration and listing of medicines and inclusion of medical devices, including IVD devices, and biologicals onto the ARTG and the ongoing monitoring and surveillance of them.